-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ILxWGqozSm1XBYwD7Wy0FVjwncCRwDoNZvCmiORBUDYjku7Os42pC1uz/A94MVyp 0S+6mT0xL+ONdV9lTUFoWA== 0000893838-98-000177.txt : 19981211 0000893838-98-000177.hdr.sgml : 19981211 ACCESSION NUMBER: 0000893838-98-000177 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19981210 FILED AS OF DATE: 19981210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AUTOIMMUNE INC CENTRAL INDEX KEY: 0000879106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133489062 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 000-20948 FILM NUMBER: 98767277 BUSINESS ADDRESS: STREET 1: 128 SPRING ST CITY: LEXINGTON STATE: MA ZIP: 02173 BUSINESS PHONE: 6178600710 MAIL ADDRESS: STREET 1: 128 SPRING STREET CITY: LEXINGTON STATE: MA ZIP: 02173 COMPANY DATA: COMPANY CONFORMED NAME: FOUR PARTNERS CENTRAL INDEX KEY: 0000942714 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: C/O B.L. BLOOM STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 212-545-2930 4 1 FORM 4 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |_| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person*: Four Partners ------------------------------ (LAST) (FIRST) (MIDDLE) c/o Thomas J. Tisch 667 Madison Avenue ------------------------------------------- (STREET) New York, New York 10021 ------------------------------------------ (CITY) (STATE) (ZIP) 2. Issuer Name and Ticker or Trading Symbol: AutoImmune, Inc. (AIMM) 3. IRS Identification Number of Reporting Person, if an entity (Voluntary): 4. Statement for Month/Year: 11/1998 1 5. If Amendment, Date of Original: (Month/Year) 6. Relationship of Reporting Person(s) to Issuer: (Check all applicable) _____ Director _____ Officer (give title below) __X__ 10% Owner _____ Other (specify below) 7. Individual or Joint/Group Filing (Check Applicable Line) __X__ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security: (Instr. 3) Common Stock, $0.01 par value 2. Transaction Date: (Month/Day/Year) 11/05/1998 11/19/1998 3. Transaction Code: 2 (Instr. 8) Code V P P 4. Securities Acquired (A) or Disposed of (D): (Instr. 3, 4 and 5) Amount (A) or (D) Price 4,900 A $1.91 25,000 A $1.87 5. Amount of Securities Beneficially Owned at End of Month: (Instr. 3 and 4) 2,022,000 6. Ownership Form: Direct (D) or Indirect (I): (Instr. 4) D 7. Nature of Indirect Beneficial Ownership: (Instr. 4) Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). 3 Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security: (Instr. 3) 2. Conversion or Exercise Price of Derivative Security: 3. Transaction Date: (Month/Day/Year) 4. Transaction Code: (Instr. 8) Code V 5. Number of Derivative Securities Acquired (A) or Disposed of (D): (Instr. 3, 4 and 5) (A) (D) 6. Date Exercisable and Expiration Date: (Month/Day/Year) Date Exercisable Expiration Date 7. Title and Amount of Underlying Securities: (Instr. 3 and 4) Title Amount or Number of Shares 4 8. Price of Derivative Security: (Instr. 5) 9. Number of Derivative Securities Beneficially Owned at End of Month: (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I): (Instr. 4) 11. Nature of Indirect Beneficial Ownership: (Instr. 4) Explanation of Responses: FOUR PARTNERS /s/ Thomas J. Tisch - -------------------------------- ** Signature of Reporting Person Date: December 10, 1998 ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of the Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. 5 -----END PRIVACY-ENHANCED MESSAGE-----